BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 27078856)

  • 1. Novel Biomarker Proteins in Chronic Lymphocytic Leukemia: Impact on Diagnosis, Prognosis and Treatment.
    Admoni-Elisha L; Nakdimon I; Shteinfer A; Prezma T; Arif T; Arbel N; Melkov A; Zelichov O; Levi I; Shoshan-Barmatz V
    PLoS One; 2016; 11(4):e0148500. PubMed ID: 27078856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VDAC1-based peptides: novel pro-apoptotic agents and potential therapeutics for B-cell chronic lymphocytic leukemia.
    Prezma T; Shteinfer A; Admoni L; Raviv Z; Sela I; Levi I; Shoshan-Barmatz V
    Cell Death Dis; 2013 Sep; 4(9):e809. PubMed ID: 24052077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel, mitochondrial, internal tRNA-derived RNA fragment possesses clinical utility as a molecular prognostic biomarker in chronic lymphocytic leukemia.
    Karousi P; Adamopoulos PG; Papageorgiou SG; Pappa V; Scorilas A; Kontos CK
    Clin Biochem; 2020 Nov; 85():20-26. PubMed ID: 32745483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein profiles distinguish stable and progressive chronic lymphocytic leukemia.
    Huang PY; Mactier S; Armacki N; Giles Best O; Belov L; Kaufman KL; Pascovici D; Mulligan SP; Christopherson RI
    Leuk Lymphoma; 2016 May; 57(5):1033-43. PubMed ID: 26422656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant expression of TRAIL in B chronic lymphocytic leukemia (B-CLL) cells.
    Secchiero P; Tiribelli M; Barbarotto E; Celeghini C; Michelutti A; Masolini P; Fanin R; Zauli G
    J Cell Physiol; 2005 Nov; 205(2):246-52. PubMed ID: 15887227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The novel member of the BCL2 gene family, BCL2L12, is substantially elevated in chronic lymphocytic leukemia patients, supporting its value as a significant biomarker.
    Papageorgiou SG; Kontos CK; Pappa V; Thomadaki H; Kontsioti F; Dervenoulas J; Papageorgiou E; Economopoulos T; Scorilas A
    Oncologist; 2011; 16(9):1280-91. PubMed ID: 21737576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. mRNA overexpression of kallikrein-related peptidase 14 (KLK14) is an independent predictor of poor overall survival in chronic lymphocytic leukemia patients.
    Kontos CK; Adamopoulos PG; Papageorgiou SG; Pappa V; Scorilas A
    Clin Chem Lab Med; 2016 Feb; 54(2):315-24. PubMed ID: 26351937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ror1, a cell surface receptor tyrosine kinase is expressed in chronic lymphocytic leukemia and may serve as a putative target for therapy.
    Daneshmanesh AH; Mikaelsson E; Jeddi-Tehrani M; Bayat AA; Ghods R; Ostadkarampour M; Akhondi M; Lagercrantz S; Larsson C; Osterborg A; Shokri F; Mellstedt H; Rabbani H
    Int J Cancer; 2008 Sep; 123(5):1190-5. PubMed ID: 18546292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of high expression of IL-9 in prognosis of CLL.
    Chen N; Lv X; Li P; Lu K; Wang X
    Int J Clin Exp Pathol; 2014; 7(2):716-21. PubMed ID: 24551294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and function of the TL1A/DR3 axis in chronic lymphocytic leukemia.
    Cavallini C; Lovato O; Bertolaso A; Zoratti E; Malpeli G; Mimiola E; Tinelli M; Aprili F; Tecchio C; Perbellini O; Scarpa A; Zamò A; Cassatella MA; Pizzolo G; Scupoli MT
    Oncotarget; 2015 Oct; 6(31):32061-74. PubMed ID: 26393680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of altered cell signaling pathways using proteomic profiling in stable and progressive chronic lymphocytic leukemia.
    Bagacean C; Iuga CA; Bordron A; Tempescul A; Pralea IE; Bernard D; Cornen M; Bergot T; Le Dantec C; Brooks W; Saad H; Ianotto JC; Pers JO; Zdrenghea M; Berthou C; Renaudineau Y
    J Leukoc Biol; 2022 Feb; 111(2):313-325. PubMed ID: 34288092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a novel, internal tRNA-derived RNA fragment as a new prognostic and screening biomarker in chronic lymphocytic leukemia, using an innovative quantitative real-time PCR assay.
    Katsaraki K; Artemaki PI; Papageorgiou SG; Pappa V; Scorilas A; Kontos CK
    Leuk Res; 2019 Dec; 87():106234. PubMed ID: 31669784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of miRNAs in Chronic Lymphocytic Leukemia Patient Samples by Quantitative Reverse Transcription PCR.
    Van Roosbroeck K; Bayraktar R; Calin GA
    Methods Mol Biol; 2019; 1881():267-276. PubMed ID: 30350212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KLKB1 mRNA overexpression: A novel molecular biomarker for the diagnosis of chronic lymphocytic leukemia.
    Adamopoulos PG; Kontos CK; Papageorgiou SG; Pappa V; Scorilas A
    Clin Biochem; 2015 Sep; 48(13-14):849-54. PubMed ID: 25891023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiopoietin-2 mRNA expression is increased in chronic lymphocytic leukemia patients with poor prognostic features.
    Vrbacky F; Smolej L; Vroblova V; Pekova S; Hrudkova M; Cervinka M; Pecka M; Krejsek J; Maly J
    Hematology; 2010 Aug; 15(4):210-4. PubMed ID: 20670479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomics-based strategies to identify proteins relevant to chronic lymphocytic leukemia.
    Alsagaby SA; Khanna S; Hart KW; Pratt G; Fegan C; Pepper C; Brewis IA; Brennan P
    J Proteome Res; 2014 Nov; 13(11):5051-62. PubMed ID: 24983324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The regulatory interaction of EVI1 with the TCL1A oncogene impacts cell survival and clinical outcome in CLL.
    Vasyutina E; Boucas JM; Bloehdorn J; Aszyk C; Crispatzu G; Stiefelhagen M; Breuer A; Mayer P; Lengerke C; Döhner H; Beutner D; Rosenwald A; Stilgenbauer S; Hallek M; Benner A; Herling M
    Leukemia; 2015 Oct; 29(10):2003-14. PubMed ID: 25936528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-92a-3p overexpression in peripheral blood mononuclear cells is an independent predictor of prolonged overall survival of patients with chronic lymphocytic leukemia.
    Papageorgiou SG; Diamantopoulos MA; Kontos CK; Bouchla A; Vasilatou D; Bazani E; Scorilas A; Pappa V
    Leuk Lymphoma; 2019 Mar; 60(3):658-667. PubMed ID: 29911923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Assessment of selected markers of apoptosis and angiogenesis in chronic lymphocytic leukemia].
    Motyčková M; Smolej L; Andrýs C; Rezáčová V; Reháček V; Simkovič M; Belada D; Zák P
    Vnitr Lek; 2013 Sep; 59(9):782-93. PubMed ID: 24073950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional evaluation of the role of inhibitor of apoptosis proteins in chronic lymphocytic leukemia.
    Schliep S; Decker T; Schneller F; Wagner H; Häcker G
    Exp Hematol; 2004 Jun; 32(6):556-62. PubMed ID: 15183896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.